Vanguard Group Inc Wave Life Sciences Ltd. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 3,206,403 shares of WVE stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,206,403
Previous 3,182,512
0.75%
Holding current value
$21 Million
Previous $39.4 Million
34.19%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$119 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$82 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$54.1 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$44.1 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$41.6 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $569M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...